C5 and chronic inflammatory demyelinating polyradiculoneuropathy: In another study examining newly diagnosed, treatment-naïve CIDP patients, C5a and soluble terminal complement complexes in serum and CSF correlated with disease severity as measured by INCAT-score at time of diagnosis, and were reduced significantly after treatment initiation with IVIg [36].